TRENDS IN LIST PRICES, NET PRICES, AND DISCOUNTS FOR SELF-ADMINISTERED DISEASE-MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS

被引：0
|
作者：
Barber, N. [1 ]
San-Juan-Rodriguez, A. [2 ]
Hernandez, I [2 ]
Good, C. B. [3 ]
Gellad, W. F. [4 ]
机构：
[1] Univ Pittsburgh, Sugarloaf, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Univ Pittsburgh, Med Ctr, Vet Hlth Adm Ctr Medicat Safety VA MedSAFE, Pittsburgh, PA USA
[4] Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI11
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [1] TRENDS IN LIST PRICES, NET PRICES, AND DISCOUNTS OF SELF-ADMINISTERED TUMOR NECROSIS FACTOR INHIBITORS
    San-Juan-Rodriguez, A.
    Piro, V
    Good, C. B.
    Gellad, W. F.
    Hernandez, I
    [J]. VALUE IN HEALTH, 2020, 23 : S16 - S16
  • [2] TRENDS IN PRICES AND SPENDING OF SELF-ADMINISTERED DISEASE-MODIFYING SPECIALTY MEDICATIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    San-Juan-Rodriguez, A.
    Good, C.
    Heyman, R. A.
    Parekh, N.
    Shrank, W. H.
    Hernandez, I
    [J]. VALUE IN HEALTH, 2019, 22 : S281 - S281
  • [3] Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D
    San-Juan-Rodriguez, Alvaro
    Good, Chester B.
    Heyman, Rock A.
    Parekh, Natasha
    Shrank, William H.
    Hernandez, Inmaculada
    [J]. JAMA NEUROLOGY, 2019, 76 (11) : 1386 - 1390
  • [4] Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors
    San-Juan-Rodriguez, Alvaro
    Piro, Vincent M.
    Good, Chester B.
    Gellad, Walid F.
    Hernandez, Inmaculada
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (01): : 112 - 117
  • [5] Addressing the Rising Prices of Disease-Modifying Therapies for Multiple Sclerosis
    Hartung, Daniel M.
    Bourdette, Dennis
    [J]. JAMA NEUROLOGY, 2019, 76 (11) : 1285 - 1287
  • [6] Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysis
    Zuckerman, Autumn D.
    DeClercq, Josh
    Simonson, Dana
    Zagel, Alicia L.
    Turco, Evan
    Banks, Aimee
    Wawrzyniak, Julie
    Rightmier, Elizabeth
    Blevins, Abbi
    Choi, Leena
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 75
  • [7] Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical Companies
    Ferris, Laura K.
    Gellad, Walid F.
    Hernandez, Inmaculada
    [J]. JAMA DERMATOLOGY, 2020, 156 (10) : 1136 - 1138
  • [8] Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition
    San-Juan-Rodriguez, Alvaro
    Gellad, Walid F.
    Good, Chester B.
    Hernandez, Inmaculada
    [J]. JAMA NETWORK OPEN, 2019, 2 (12)
  • [9] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [10] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    [J]. NEUROLOGY, 2011, 77 (04) : E26 - E26
12345